HIGHLIGHTS
- who: Gregory T. Havlena and collaborators from the University School have published the research work: Cure of Micrometastatic B-Cell Lymphoma in a SCID Mouse Model Using 213Bi-Anti-CD20 Monoclonal Antibody, in the Journal: (JOURNAL)
- what: The experiments the authors conducted used a bioluminescent imaging (BLI) reporter system for real-time monitoring of treatment response, affording a sensitive view of in_vivo tumor kill kinetics in a very low tumor burden . 211 At-IF5 (anti-CD20 antibody) slowed tumor growth in subcuOur studies have demonstrated several important findings: 213Bi- taneous lymphoma tumor xenografts but did . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.